BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38188143)

  • 1. The expression and clinical significance of serine hydroxymethyltransferase2 in gastric cancer.
    Shan Y; Liu D; Li Y; Wu C; Ye Y
    PeerJ; 2024; 12():e16594. PubMed ID: 38188143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients.
    Shi H; Fang X; Li Y; Zhang Y
    Med Sci Monit; 2019 Oct; 25():7430-7438. PubMed ID: 31581160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of SHMT2 is correlated with tumor progression and predicts poor prognosis in gastrointestinal tumors.
    Liu Y; Yin C; Deng MM; Wang Q; He XQ; Li MT; Li CP; Wu H
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9379-9392. PubMed ID: 31773687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
    Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y
    Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.
    Ji L; Tang Y; Pang X; Zhang Y
    Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma.
    Wang B; Wang W; Zhu Z; Zhang X; Tang F; Wang D; Liu X; Yan X; Zhuang H
    Clin Neurol Neurosurg; 2017 Mar; 154():28-33. PubMed ID: 28107674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Mitochondrial Serine Hydroxymethyltransferase 2 (SHMT2) in Human Carcinogenesis.
    Zeng Y; Zhang J; Xu M; Chen F; Zi R; Yue J; Zhang Y; Chen N; Chin YE
    J Cancer; 2021; 12(19):5888-5894. PubMed ID: 34476002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling.
    Wang W; Wang M; Du T; Hou Z; You S; Zhang S; Ji M; Xue N; Chen X
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma.
    Ning S; Ma S; Saleh AQ; Guo L; Zhao Z; Chen Y
    Gastroenterol Res Pract; 2018; 2018():4369253. PubMed ID: 30228815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma.
    Luo L; Zheng Y; Lin Z; Li X; Li X; Li M; Cui L; Luo H
    J Immunol Res; 2021; 2021():6647122. PubMed ID: 33928169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer.
    Jin M; Lee WK; You MH; Jang A; Cheng SY; Kim WG; Jeon MJ; Lee YM
    Endocr Connect; 2021 Jun; 10(6):630-636. PubMed ID: 34010151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of SHMT2 enhances the sensitivity of gastric cancer cells to radiotherapy through the Wnt/β-catenin pathway.
    Mao Y; Zhang T
    Open Life Sci; 2022; 17(1):1249-1255. PubMed ID: 36213384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of PSCA promotes gastric cancer proliferation and is related to poor prognosis.
    Xu LP; Qiu HB; Yuan SQ; Chen YM; Zhou ZW; Chen YB
    J Cancer; 2020; 11(9):2708-2715. PubMed ID: 32201541
    [No Abstract]   [Full Text] [Related]  

  • 14. Exosome-mediated transfer of circ_0063526 enhances cisplatin resistance in gastric cancer cells via regulating miR-449a/SHMT2 axis.
    Yang G; Tan J; Guo J; Wu Z; Zhan Q
    Anticancer Drugs; 2022 Nov; 33(10):1047-1057. PubMed ID: 36206102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drosha-independent miR-6778-5p strengthens gastric cancer stem cell stemness via regulation of cytosolic one-carbon folate metabolism.
    Zhao M; Hou Y; Du YE; Yang L; Qin Y; Peng M; Liu S; Wan X; Qiao Y; Zeng H; Cui X; Teng Y; Liu M
    Cancer Lett; 2020 May; 478():8-21. PubMed ID: 32142918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer.
    Wang H; Chong T; Li BY; Chen XS; Zhen WB
    Biol Res; 2020 Oct; 53(1):46. PubMed ID: 33066813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression.
    Cui X; Cui Y; Du T; Jiang X; Song C; Zhang S; Ma C; Liu Y; Ni Q; Gao Y; Wang G
    Can J Gastroenterol Hepatol; 2022; 2022():3758697. PubMed ID: 35211429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer.
    Chu XD; Lin ZB; Huang T; Ding H; Zhang YR; Zhao Z; Huangfu SC; Qiu SH; Guo YG; Chu XL; Pan JH; Pan YL
    BMC Cancer; 2022 Mar; 22(1):250. PubMed ID: 35255858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive correlation between expression level of mitochondrial serine hydroxymethyltransferase and breast cancer grade.
    Yin K
    Onco Targets Ther; 2015; 8():1069-74. PubMed ID: 25999742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.